Pharsight

Trelstar patents expiration

TRELSTAR's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5776885 VERITY Sustained and controlled release of water insoluble polypeptides
Jul, 2015

(8 years ago)

US10166181 VERITY Slow release pharmaceutical composition made of microgranules
Jun, 2029

(5 years from now)

Trelstar is owned by Verity.

Trelstar contains Triptorelin Pamoate.

Trelstar has a total of 2 drug patents out of which 1 drug patent has expired.

Expired drug patents of Trelstar are:

  • US5776885

Trelstar was authorised for market use on 29 June, 2001.

Trelstar is available in injectable;intramuscular dosage forms.

The generics of Trelstar are possible to be released after 30 June, 2029.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using TRIPTORELIN PAMOATE ingredient

Market Authorisation Date: 29 June, 2001

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR

More Information on Dosage

TRELSTAR family patents

Family Patents